Knockout of the uPAR gene by CRISPR gene knockout technology can lead to tumor cell apoptosis, increase the sensitivity of tumor cells to chemotherapy drugs, and down-regulate EGFR expression, suggesting that uPAR can be used as a therapeutic target for colon cancer (134). This evidence concerns the gene PLAUR and neoplasm.